Study guide
11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules
Oregon Multistate Pharmacy Jurisprudence Examination MPJE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Oregon Legal Framework
1.1 Oregon MPJE Format, Fees, Blueprint & 2027 Changes 1.2 Federal–Oregon Legal Hierarchy, Agencies & the Board of Pharmacy
2 Chapter 2: Pharmacist & Pharmacist-in-Charge Responsibilities
2.1 Pharmacist Responsibilities, Supervision & Prohibited Practices 2.2 Pharmacist-in-Charge: Qualifications, Duties, Inventories & Self-Inspection
3 Chapter 3: Pharmacy Technicians, Interns & Preceptors
3.1 Pharmacy Technicians (COPT & PT): Licensure, Permitted Tasks & Limits 3.2 Pharmacy Interns & Preceptors: Licensure, Scope & Supervision
4 Chapter 4: Licensure, Renewal, Discipline & Impaired Practitioners
4.1 Pharmacist Licensure by Examination, Score Transfer & Reciprocity 4.2 License Renewal, Continuing Pharmacy Education & Lapse Rules 4.3 Grounds for Discipline, Sanctions & Mandatory Reporting Deadlines 4.4 Impaired Practitioners & the Health Professionals' Services Program (HPSP)
5 Chapter 5: Prescriber Authority & Prescription Requirements
5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions 5.2 Non-Controlled Prescriptions: Required Elements, Signatures, Expiration & Refills 5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit 5.4 Drug-Use Limitations & Special Prescriptions: REMS, Death with Dignity, EPT & Standing Orders 5.5 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
6 Chapter 6: Pharmacist Clinical Services & Prescriptive Authority
6.1 CDTM, Clinical Pharmacy Agreements, MTM & Laboratory Testing 6.2 Pharmacist Prescribing: Statewide Protocols, the Formulary & General Requirements 6.3 Pharmacist Prescribing of Hormonal Contraception (ORS 689.689) 6.4 Tobacco Cessation Protocol: Training, Screening, NRT & Non-NRT Prescribing 6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS 6.6 Opioid Overdose Reversal & MOUD: Naloxone Prescribing, Standing Orders, Immunity & Buprenorphine
7 Chapter 7: Counseling, Language Access & Confidentiality
7.1 Patient Counseling: Triggers, Who May Offer or Accept a Refusal & Documentation 7.2 Language Access & Accessibility: Dual-Language Labels, Registry Interpreters & Prescription Readers 7.3 Patient Confidentiality: Oregon Rules, HIPAA, Part 2 & PDMP Privacy
8 Chapter 8: The Dispensing Process
8.1 Prospective Drug Utilization Review: Oregon's Eight Categories, Documentation & Who May Perform It 8.2 Oregon PDMP: Reporting Within 72 Hours, Covered Drugs, Access & Confidentiality 8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits 8.4 Dispensing Exceptions: 72-Hour Emergency Refills, Continuation of Therapy, Insulin & Declared Emergencies 8.5 Partial Fills: Schedule II (72-Hour, 30-Day CARA & 60-Day LTCF/Terminal) and Schedules III–V 8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks 8.7 Packaging: PPPA Child-Resistant Containers, Waivers, Exemptions & Oregon's New-Container Rule 8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
9 Chapter 9: Nonprescription & Restricted Products
9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging 9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others
10 Chapter 10: Product Selection: Generic & Biologic Substitution
10.1 Product Selection: Generic Substitution (ORS 689.515) & Biologic Interchange (ORS 689.522)
11 Chapter 11: Acquisition, Records, Inventories & Loss Reporting
11.1 Ordering & Acquiring Controlled Substances: DEA Registration, Form 222, CSOS & the 5% Rule 11.2 Distribution Records, DSCSA, Recalls & Oregon Record Retention 11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules 11.4 Theft & Loss Reporting, Disposal, Reverse Distribution & Take-Back Receptacles
12 Chapter 12: Pharmacy Operations, Storage, Security & Special Practice Settings
12.1 Pharmacy Operations: Pharmacist Presence, Policies, Equipment, Signage, Hours & Closures 12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units 12.3 Security & Non-Pharmacist Access: Keys, Double Set-Ups, Institutional Night Access & DEA Controls 12.4 Hazardous Drugs: NIOSH 2024 List, USP 800 Controls, Assessment of Risk & Disposal 12.5 Compounding: OAR 855-183 (June 2026), USP 795/797/800, 503A vs. 503B & Beyond-Use Dates 12.6 Delivery of Drugs: Depots, Mail Delivery, Prescription Lockers, Kiosks & Mobile Pharmacies 12.7 Central Fill, Remote Processing, Telework & Remote Dispensing Site Pharmacies
13 Chapter 13: Drug Outlet Registration, Inspection & Institutional Practice
13.1 Drug Outlet Classes, Registration, Changes of Ownership/Location/Name & Non-Resident Pharmacies 13.2 Inspections, Self-Inspection Forms & Discipline of Drug Outlets 13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks
11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules
Key Takeaways Explain This Topic AI
Oregon requires a written, reconciled inventory of all controlled substances within 367 days of the last one, while federal law requires one only every two years.
In Oregon, Schedule II drugs must be inventoried and reconciled at least every 93 days in retail outlets and every 31 days in institutional outlets.
When the PIC changes, an Oregon pharmacy must complete a full controlled substance inventory with discrepancy reconciliation within 15 days.
Under federal rules, Schedule I–II drugs and Schedule III–V containers holding more than 1,000 units are counted exactly; other opened Schedule III–V containers may be estimated.
The Oregon Board says an on-hand count is not a reconciliation; every discrepancy must be documented and explained, including will-call, e-kit, compounding and expired stock.
Last updated: October 2026
Why this matters
Inventory questions are among the most Oregon-specific on the exam. Federal law requires a controlled-substance inventory only every two years . Oregon requires a reconciled inventory of all controlled substances within 367 days of the last one, a Schedule II reconciliation every 93 days in retail (31 days in institutional) pharmacies, and a full inventory within 15 days of a PIC change .
Federal baseline (21 CFR 1304.11)
- Event Federal requirement
- Initial inventory On the date the registrant first engages in dispensing. Record zero if there is no stock
- Biennial inventory At least every two years , on any date within two years of the previous one
- Newly controlled substance Inventory of that substance on the effective date it is scheduled
- Timing notation Taken at the opening or close of business, and the record says which
Counting Schedule I–II: exact count. Schedule III–V: estimated count of opened containers, unless the container holds more than 1,000 tablets or capsules, which requires an exact count
"On hand" Includes drugs returned by customers and awaiting disposal, drugs ordered but not yet invoiced, and drugs stored for the registrant elsewhere
Oregon requirements
Oregon rule Requirement
OAR 855-080-0070 A written inventory of all controlled substances annually, within 367 days of the last written inventory. Records kept 3 years
OAR 855-115-0210(1)(i) The PIC ensures a controlled-substance inventory with discrepancy reconciliation for all controlled drugs , taken before opening or after closing on the inventory date, within 15 days of a change in PIC and at least every 367 days
OAR 855-115-0210(1)(i) Schedule II inventory with reconciliation at least every 93 days in a retail drug outlet and at least every 31 days in an institutional drug outlet
OAR 855-139 Remote dispensing site pharmacies with controlled substances keep a perpetual inventory reconciled every 28 days
What "reconciliation" means to the Board
The Board's 2026 self-inspection form explains:
A reconciliation is "an accurate accounting of the outlet's true inventory." A bare on-hand count is not enough .
The pharmacy compares the count with what should be there: the last inventory plus receipts, minus dispensing, transfers, returns and destruction. Every discrepancy must be documented and clearly explained .
Even when there are no discrepancies , keep documentation showing the reconciliation was done, such as investigative notes or a screenshot.
The inventory must include will-call prescriptions awaiting pickup, drugs in long-term care emergency kits , drugs used for compounding , refrigerated items, stock in automated dispensing machines and outdated controlled substances awaiting disposal.
A pharmacy that is not open 24 hours notes whether the count was taken before opening or after closing .
What the inventory record contains (21 CFR 1304.11)
For each controlled substance in finished form, the inventory lists:
The name of the substance.
Each finished form , for example a 10 mg tablet.
The number of units or volume per commercial container , for example a 100-tablet bottle.
The number of commercial containers .
Opened containers are counted exactly or estimated under the rule above. The record is dated, says whether it was taken at the opening or close of business, and is kept at the registered location. Schedule II inventories are filed separately from other records. Oregon requires retention for three years (OAR 855-080-0070).
Triggered inventories
Change of PIC: a full Schedule II–V inventory with reconciliation within 15 days , alongside the new PIC's self-inspection.
Newly scheduled drug: an inventory on the date the scheduling takes effect (federal), after which it joins the regular cycle.
Permanent closure: a controlled-substance inventory on the closing date or within 24 hours, plus DEA notification of transfers (OAR 855-041-1092; 21 CFR 1301.52).
Theft or significant loss: an inventory is the practical first step in determining the loss for the 1-business-day report (section 11.4).
Building a compliant calendar
Loading diagram...
A retail pharmacy that does its full inventory on January 15 must:
Reconcile Schedule II no later than April 18 (93 days).
Reconcile Schedule II again within 93 days of each prior reconciliation.
Complete the next full inventory by January 17 of the following year (367 days, in a non-leap year).
A biennial federal inventory alone would leave the pharmacy out of compliance with Oregon law.
Warning
The 367-day , 93-day and 31-day periods are maximums between events, not calendar-quarter deadlines. Counting a Schedule II reconciliation in February and then in July violates the 93-day rule, even though each falls in a different quarter.
Exam scenario
A hospital pharmacy's last Schedule II reconciliation was March 1. On April 5, a compliance officer finds that no reconciliation has occurred since. As an institutional drug outlet, the hospital needed a Schedule II reconciliation within 31 days , by April 1 , so it is out of compliance. A retail pharmacy with the same dates would have had until June 2 . In either case, a count without a documented reconciliation of discrepancies would not satisfy the rule.